Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F5Q15
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,671
Award facts
- Contract value 100% obligated
- $45,671.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 28, 2025, for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The delivery order, valued at $45,671.04, is scheduled for completion by December 1, 2025, and represents a non-competitive award executed under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). This prime IDC, valued at $999,999,999.00 and extending through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The award supports the Defense Logistics Agency's medical supply chain operations, which serve critical healthcare needs across the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems. AmerisourceBergen's established position as a major pharmaceutical distributor and federal vendor, demonstrated through its extensive portfolio of competitive contract awards covering multiple therapeutic domains, positions the company to fulfill this delivery requirement for the brand-name anticoagulant medication. The non-set-aside designation reflects the open competitive nature of the underlying indefinite delivery contract vehicle, which continues to be a key mechanism for federal pharmaceutical procurement supporting military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5Q15?
SPE2DR26F5Q15 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26F5Q15 worth?
The government has obligated $45,671 on SPE2DR26F5Q15.
Is contract SPE2DR26F5Q15 an order under another contract?
Yes. SPE2DR26F5Q15 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Q15 competed?
The extent of competition for SPE2DR26F5Q15 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award